Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

Bullboard (NYSEAM:YMI)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Comment by greatemailslobon Jan 25, 2010 3:09pm

RE: Trades @ 1.96 ??

noget a life
242
Discussion
Post by grootvader2009on Jan 22, 2010 7:35pm

Trades @ 1.96 ??

Anybody see those go thru?3 times 18000 shares   -   they are cash sales according to the marker at stockwatch
356
Post by greatemailslobon Jan 22, 2010 3:38pm

slob homer

YM BioSciences inc 1.82CAD0.10(5.81%)Volume: Above Average Add to Watchlist As of 22 Jan 2010 at 3:37 PM EST
271
Post by greatemailslobon Jan 20, 2010 10:04am

Dundee Securities

at the J.P. Morgan Healthcare Conference in San Francisco last week, Dundee Securities issued its latest biotech sector update. On the bright side, analyst David Martin is also keeping an eye on YM ...more  
808
Post by ragman5on Jan 11, 2010 9:03am

News

Looks like more good news today!
481
Comment by stellar8on Jan 07, 2010 1:56pm

RE: YM TO ROCK TODAY

When did Roth put the $6 target out?
479
Discussion
Post by greatemailslobon Jan 07, 2010 8:34am

YM TO ROCK TODAY

 Coverage InitiatedSort alphabetically | Sort by brokers Company Ticker Brokerage Firm Ratings Change Price Target  ...more  
908
Post by SanMiguelGto1on Dec 28, 2009 2:35pm

FYI

clinical results expected shortly.shorts are keeping it in the 1.25 range so you have lots of time to take a position
238
Post by SanMiguelGto1on Dec 19, 2009 10:27am

Look at the short intestest coming out

Dec 24thOne day spring 2010 we will be squeezing their lemons and watch as the juice runs down their legs.  I didn't make that up.  :)
559
Comment by CatchinTheKnifeon Dec 17, 2009 4:26pm

RE: RE: REVERSAL IN SHARE PRICE AGAIN

The North American markets are notorious for this type of manipulation.  Institutions and banks will often drive down or hold down a share price in order to maximize the amount of shares they ...more  
424
Discussion
Comment by rooki14on Dec 16, 2009 9:08am

RE: REVERSAL IN SHARE PRICE AGAIN

Could be that they want to keep price of merger down.Just a thoughtRooki
390
Discussion
Post by cacfaon Dec 15, 2009 11:44am

REVERSAL IN SHARE PRICE AGAIN

Again, we see share price go down shortly after release of good news.  Seems like somebody is trying to keep share price in tight trading range - $1.15 to $1.30.  Volume is low so relatively ...more  
398
Post by greatemailslobon Dec 11, 2009 10:45am

buying more

bings position to 40000target 3 bucks for a flip
459
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities